Key Insights

Highlights

Success Rate

33% trial completion

Treatment Research

3 treatments under study, led by Cashew Or Shrimp Oral Immunotherapy

Research Leaders

5 sponsors active, led by Sayantani B. Sindher

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

66.7%

2 terminated out of 3 trials

Success Rate

33.3%

-53.3% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed with results

Key Signals

2 with results33% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 2 (1)

Trial Status

Terminated2
Completed1

Trial Success Rate

33.3%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Cashew Or Shrimp Oral Immunotherapy1
  • Shrimp Allergy With Intend To Eat Shrimp1
  • Treatment Chinese Herbal Formula X1

Active Sponsors

  • Sayantani B. Sindher1
  • Chinese University of Hong Kong1
  • Mahidol University1
  • National Institute of Allergy and Infectious Diseases (NIAID)1
  • Hong Kong Sanatorium & Hospital1

Top Investigators

Related Conditions

  • Allergy To Fish1
  • Allergyfood1
  • Allergy To Cashew Nut Disorder1
  • Immunotherapy1
  • Allergy To Crab1

Activity Timeline